![](https://img.einnews.com/small/714403/viscardia.png)
VisCardia Receives US FDA IDE Approval to Start the RECOVER HF Clinical Study
PORTLAND, OREGON, UNITED STATES, July 30, 2024 /EINPresswire.com/ -- VisCardia, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of an Investigational Device Exemption (IDE) to study the safety and effectiveness of the …